Publisher： Bentham Science Publishers
E-ISSN： 2212-3938|6|3|199-206
ISSN： 1574-8847
Source： Current Clinical Pharmacology, Vol.6, Iss.3, 2011-08, pp. : 199-206
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Dual Inhibition of PI3-Kinase and mTOR in Renal Cell Carcinoma
Current Cancer Drug Targets, Vol. 13, Iss. 2, 2013-02 ,pp. :
Emerging drugs for renal cell carcinoma
By Varella Leticia Rini Brian I
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. :
Emerging drugs for renal cell carcinoma
By Shaheen Philip E Bukowski Ronald M
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. :
Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma
Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. :